Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Other Accumulated Expenses (2016 - 2025)

Innovate has reported Other Accumulated Expenses over the past 16 years, most recently at $16.9 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 1.74% year-over-year to $16.9 million; the TTM value through Dec 2025 reached $16.9 million, down 1.74%, while the annual FY2025 figure was $16.9 million, 1.74% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $16.9 million at Innovate, down from $17.0 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $24.7 million in Q1 2023 and troughed at $14.2 million in Q1 2021.
  • A 5-year average of $17.9 million and a median of $17.2 million in 2023 define the central range for Other Accumulated Expenses.
  • On a YoY basis, Other Accumulated Expenses climbed as much as 41.86% in 2021 and fell as far as 99.69% in 2021.
  • Year by year, Other Accumulated Expenses stood at $18.3 million in 2021, then increased by 9.84% to $20.1 million in 2022, then decreased by 19.9% to $16.1 million in 2023, then rose by 6.83% to $17.2 million in 2024, then decreased by 1.74% to $16.9 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for VATE at $16.9 million in Q4 2025, $17.0 million in Q3 2025, and $17.2 million in Q2 2025.